China Pharmaceuticals Q1 Total Revenue Up
The company posted net income of $1.54m for the first quarter of 2010, a decrease of 14 percent, compared to $1.8m for the prior year period. Gross profit increased 53 percent to $4.23m, compared to $2.76m for the same quarter in 2009.
Operating income for the first quarter decreased by three percent to $2.11m from $2.18m for the year ago period, due to an increase in selling and general administrative expenses that were a factor in driving the increase in sales for the period.
Guozhu Wang, chairman and CEO of China Pharmaceuticals, said: “We are focused on continuing to expand our portfolio of high margin products that address major disease categories and on continuing to build sustainable growth in revenues and profits.
“Fiscal 2010 is expected to be a transitional year for the company as we prepare for the introduction of new drugs and pursue additional opportunities for both organic growth and potential strategic acquisitions. We remain very confident regarding our future growth prospects and look forward to sharing further details with our shareholders as our expansion plans reach a definitive stage.”
Will China Pharmaceuticals further improve net income in Q2?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.